Easy Branches allows you to share your guest post within our network in any countries of the world to reach Global customers start sharing your stories today!

Easy Branches

34/17 Moo 3 Chao fah west Road, Phuket, Thailand, Phuket

Call: 076 367 766

info@easybranches.com

Financial Markets

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Vimta Labs through its diagnostic and pathological services business has recorded a revenue of Rs 30 crore during FY 2024 and Rs 7 crore in Q1 FY 2025.

By: business-standard.com

Aug 30 2024
0
0 Views

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Related

RVNL jumps after bagging LoA worth Rs 202-cr railway project

Eraaya Lifespaces completes acquisition of Ebix Inc.

Jai Corp board OKs Rs 118-cr share buyback

Ravinder Heights Ltd leads gainers in 'B' group

Thyrocare to acquire diagnostic and pathological services of Vimta Lab

Eight-day rally takes Airtel's m-cap over Rs 9.5 trn; stock hits new high

Garden Reach inks MoU with National Highway Infrastructure; shares up 7%

Nifty climbs above 25,250; consumer durables shares advance

Torrent Pharma rallies 4% as USFDA issues EIR for Gujarat facility

ECOS Mobility IPO ends today: should you bid? Check GMP & other details

M&M gains as Mahindra Group ties up with Sentrycs to explore anti-drone solutions

SBI Card loses credit card market share in July; InCred retains 'Reduce'

RVNL jumps after bagging LoA worth Rs 202-cr railway project